Information services company Wolters Kluwer, Netherlands, has announced that it has sold its pharma-related Healthcare Analytics business to private equity firm Symphony Technology Group (STG). While terms of the sale were not disclosed, Wolters Kluwer will retain a minority interest in a newly created STG entity going forward as part of the agreement.
Healthcare Analytics claims to be a leader in comprehensive patient and physician-level prescription and usage data to the pharmaceutical industry. STG's portfolio companies capture high value data around physicians' treatment decisions in response to pharmaceutical promotion.
The sale is part of the divestiture programme of Wolters Kluwer's pharma-related assets, originally announced in July 2011. The Healthcare Analytics unit was reported as part of discontinued business in Wolters Kluwer's 2011 results.
